Radiation dose during catheter ablation in children using a low fluoroscopy frame rate.


Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 11 08 2021
revised: 29 01 2022
accepted: 01 02 2022
pubmed: 13 3 2022
medline: 6 5 2022
entrez: 12 3 2022
Statut: ppublish

Résumé

Catheter ablation (CA) in children using fluoroscopy carries risks inherent to ionizing radiation exposure. The objective of this study was to demonstrate the feasibility of using low frames rate during ablation in children to maximally decrease radiation dose. Hundred sixty eight successive patients<18 years of age undergoing CA performed under a 3.75 frames/second rate were retrospectively included. Demographics, procedural and dosimetry data were analysed. The effective dose (ED) was evaluated in a subgroup of 14 patients. Median age and weight were 15 years and 54kg, 72% had WPW, 10% AV node reentrant tachycardia, 10% ventricular tachycardia (atrial tachycardia, flutter and atrial fibrillation for the other cases). Acute success was achieved in 98.5% without any complication. Median procedure and fluoroscopy duration were 120 and 16minutes. Median Dose Area Product (DAP) and Air Kerma were 2.46Gy.cm Low frame rate fluoroscopy is a highly effective and safe approach in decreasing radiation exposure during CA in children without altering the success rate of the procedure. ED is low, similar to natural/leisure irradiation. This approach can be considered a good alternative to 3D-based procedures in terms of efficiency and radiation issues, at least for WPW ablations.

Sections du résumé

BACKGROUND BACKGROUND
Catheter ablation (CA) in children using fluoroscopy carries risks inherent to ionizing radiation exposure.
AIMS OBJECTIVE
The objective of this study was to demonstrate the feasibility of using low frames rate during ablation in children to maximally decrease radiation dose.
METHODS METHODS
Hundred sixty eight successive patients<18 years of age undergoing CA performed under a 3.75 frames/second rate were retrospectively included. Demographics, procedural and dosimetry data were analysed. The effective dose (ED) was evaluated in a subgroup of 14 patients.
RESULTS RESULTS
Median age and weight were 15 years and 54kg, 72% had WPW, 10% AV node reentrant tachycardia, 10% ventricular tachycardia (atrial tachycardia, flutter and atrial fibrillation for the other cases). Acute success was achieved in 98.5% without any complication. Median procedure and fluoroscopy duration were 120 and 16minutes. Median Dose Area Product (DAP) and Air Kerma were 2.46Gy.cm
CONCLUSION CONCLUSIONS
Low frame rate fluoroscopy is a highly effective and safe approach in decreasing radiation exposure during CA in children without altering the success rate of the procedure. ED is low, similar to natural/leisure irradiation. This approach can be considered a good alternative to 3D-based procedures in terms of efficiency and radiation issues, at least for WPW ablations.

Identifiants

pubmed: 35277353
pii: S1875-2136(22)00034-1
doi: 10.1016/j.acvd.2022.02.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-159

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

Maya Riche (M)

Department of cardiology, university hospital Rangueil, Toulouse, France.

Sylvie Monfraix (S)

Unité de radiophysique et radioprotection, university hospital, Toulouse, France.

Sebastien Balduyck (S)

Unité de radiophysique et radioprotection, university hospital, Toulouse, France.

Quentin Voglimacci-Stephanopoli (Q)

Department of cardiology, university hospital Rangueil, Toulouse, France.

Anne Rollin (A)

Department of cardiology, university hospital Rangueil, Toulouse, France.

Pierre Mondoly (P)

Department of cardiology, university hospital Rangueil, Toulouse, France.

Franck Mandel (F)

Department of cardiology, university hospital Rangueil, Toulouse, France.

Maxime Beneyto (M)

Department of cardiology, university hospital Rangueil, Toulouse, France.

Hubert Delasnerie (H)

Department of cardiology, university hospital Rangueil, Toulouse, France.

Nicolas Derval (N)

Department of cardiology, IHU Liryc, electrophysiology and heart modeling Institute, university Bordeaux, Bordeaux university hospital (CHU), 33600 Pessac-Bordeaux, France.

Jean Benoit Thambo (JB)

Department of cardiology, IHU Liryc, electrophysiology and heart modeling Institute, university Bordeaux, Bordeaux university hospital (CHU), 33600 Pessac-Bordeaux, France.

Clement Karsenty (C)

Children hospital, university hospital, Toulouse, France.

Yves Dulac (Y)

Children hospital, university hospital, Toulouse, France.

Philippe Acar (P)

Children hospital, university hospital, Toulouse, France.

Stéphanie Mora (S)

Unité de radiophysique et de radioprotection, CHU de Bordeaux, Bordeaux, France.

Romain Gautier (R)

Unité de radiophysique et de radioprotection, CHU de Bordeaux, Bordeaux, France.

Frederic Sacher (F)

Department of cardiology, IHU Liryc, electrophysiology and heart modeling Institute, university Bordeaux, Bordeaux university hospital (CHU), 33600 Pessac-Bordeaux, France.

Philippe Maury (P)

Department of cardiology, university hospital Rangueil, Toulouse, France; I2MC, Inserm UMR 1297, Toulouse, France. Electronic address: mauryjphil@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH